Mundipharma AB
- A10 - Antidiabéticos
- INVOKANA film-coated tablet 100 mg
- INVOKANA film-coated tablet 300 mg
- VOKANAMET film-coated tablet 1 000 mg+150 mg
- VOKANAMET film-coated tablet 1 000 mg+50 mg
- VOKANAMET film-coated tablet 850 mg+150 mg
- VOKANAMET film-coated tablet 850 mg+50 mg
- L01 - Antineoplásicos
- DEPOCYTE solution for injection 50 mg/5 ml
- RIBOVACT powder for solution for infusion 100 mg
- RIBOVACT powder for solution for infusion 25 mg
- L03 - Inmunoestimulantes
- CEGFILA I FÖRFYLLD SPRUTA solution for injection 6 mg
- PELMEG I FÖRFYLLD SPRUTA solution for injection 6 mg
- N02 - Analgésicos
- ARMONEVE prolonged-release tablet 10 mg+5 mg
- ARMONEVE prolonged-release tablet 15 mg+7.5 mg
- ARMONEVE prolonged-release tablet 2.5 mg+1.25 mg
- ARMONEVE prolonged-release tablet 20 mg+10 mg
- ARMONEVE prolonged-release tablet 30 mg+15 mg
- ARMONEVE prolonged-release tablet 40 mg+20 mg
- ARMONEVE prolonged-release tablet 5 mg+2.5 mg
- DOLCONTIN prolonged-release tablet 10 mg
- DOLCONTIN prolonged-release tablet 100 mg
- DOLCONTIN prolonged-release tablet 200 mg
- DOLCONTIN prolonged-release tablet 30 mg
- DOLCONTIN prolonged-release tablet 5 mg
- DOLCONTIN prolonged-release tablet 60 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 120 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 150 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 200 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 30 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 60 mg
- DOLCONTIN UNOTARD prolonged-release capsule, hard 90 mg
- NORSPAN transdermal patch 10 µg/h
- NORSPAN transdermal patch 15 µg/h
- NORSPAN transdermal patch 20 µg/h
- NORSPAN transdermal patch 25 µg/h
- NORSPAN transdermal patch 30 µg/h
- NORSPAN transdermal patch 40 µg/h
- NORSPAN transdermal patch 5 µg/h
- OXYCONTIN prolonged-release tablet 10 mg
- OXYCONTIN prolonged-release tablet 20 mg
- OXYCONTIN prolonged-release tablet 40 mg
- OXYCONTIN prolonged-release tablet 5 mg
- OXYCONTIN prolonged-release tablet 80 mg
- OXYNORM capsule, hard 10 mg
- OXYNORM capsule, hard 20 mg
- OXYNORM capsule, hard 5 mg
- OXYNORM oral solution 1 mg/ml
- OXYNORM oral solution 10 mg/ml
- OXYNORM solution for injection 10 mg/1 ml
- OXYNORM solution for injection 20 mg/2 ml
- OXYNORM solution for injection 200 mg/20 ml
- PALLADON solution for injection 10 mg/1 ml
- PALLADON solution for injection 2 mg/1 ml
- PALLADON solution for injection 20 mg/1 ml
- PALLADON solution for injection 50 mg/1 ml
- TARGINIQ prolonged-release tablet 10 mg+5 mg
- TARGINIQ prolonged-release tablet 20 mg+10 mg
- TARGINIQ prolonged-release tablet 40 mg+20 mg
- TARGINIQ prolonged-release tablet 5 mg+2.5 mg
- R02 - Preparados para la garganta
- NYODEX concentrate for gargle 75 mg/ml
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ABRIFF pressurised inhalation, suspension 10 µg/dose+250 µg/dose
- ABRIFF pressurised inhalation, suspension 5 µg/dose+125 µg/dose
- ABRIFF pressurised inhalation, suspension 5 µg/dose+50 µg/dose
- AFFERA pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- AFFERA pressurised inhalation, suspension 250 µg/dose+10 µg/dose
- AFFERA pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- FLUTIFORM K-HALER pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- FLUTIFORM K-HALER pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- FLUTIFORM pressurised inhalation, suspension 125 µg/dose+5 µg/dose
- FLUTIFORM pressurised inhalation, suspension 250 µg/dose+10 µg/dose
- FLUTIFORM pressurised inhalation, suspension 50 µg/dose+5 µg/dose
- V03 - Todos los demás preparados terapéuticos
- NYXOID nasal spray, solution 1.8 mg